The efficacy and safety of adjuvant immunotherapy after neoadjuvant immunotherapy combined with chemotherapy in locally advanced resectable esophageal squamous cell carcinoma: a real−world study

BackgroundThe promising therapeutic outcomes of neoadjuvant immunotherapy with chemotherapy (NAIC) in the treatment of resectable locally advanced esophageal squamous cell carcinoma (LA-ESCC) have been confirmed by several clinical trials. However, the potential benefits of adjuvant therapy for LA-E...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Xue Wu, Fangjie Ding, Shunshun Bao, Yiming Mu, Jiandong Zhang, Shuming Zhang, Pingping Hu, Yan Zhang, Ning Liang, Guodong Deng, Yuying Hao, Xinquan Liang, Fengxue Li, Yang Shu, Jingxin Zhang, Lili Qiao, Yingying Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Subjects:	adjuvant therapy neoadjuvant therapy immunotherapy chemotherapy esophageal squamous cell carcinoma (ESCC)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1555756/full